首页> 外文期刊>Indian heart journal >Hiroki Mizoguchi, Aiko Ogawa, Mitsuru Munemasa, Hiroshi Mikouchi, Hiroshi Ito, Hiromi Matsubara, Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension. Circ Car-diovasc Interv 2012;5:748-755.
【24h】

Hiroki Mizoguchi, Aiko Ogawa, Mitsuru Munemasa, Hiroshi Mikouchi, Hiroshi Ito, Hiromi Matsubara, Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension. Circ Car-diovasc Interv 2012;5:748-755.

机译:宫口裕树(Hiroki Mizoguchi),小川爱子(Aiko Ogawa),Munisuru Munemasa,三口洋史(Hiroshi Mikouchi),伊藤洋史(Hiroshi Ito),松原裕美(Hiromi Matsubara),用于无法手术的慢性血栓栓塞性肺动脉高压患者的气囊肺血管成形术。Circ Car-diovasc Interv 2012; 5:748-755。

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Although balloon pulmonary angioplasty (BPA) for inoperable patients with chronic thromboembolic pulmonary hypertension was first reported over a decade ago, its clinical application has been restricted because of limited efficacy and complications. We have refined the procedure of BPA to maximize its clinical efficacy.Methods and results: Sixty-eight consecutive patients with inoperable chronic thromboembolic pulmonary hypertension (CTEPH) underwent BPA. We evaluated pulmonary artery diameters and determined the appropriate balloon size by using intravascular ultrasound. We performed BPA in a staged fashion over multiple, separate procedures to maximize efficacy and reduce the risk of reperfusion pulmonary injury. A total of 4 (2-8) sessions were performed in each patient, and the number of vessels dilated per session was 3 (1-14).
机译:背景:尽管十多年前首次报道了无法手术的慢性血栓栓塞性肺动脉高压患者的球囊肺血管成形术(BPA),但由于疗效和并发症有限,其临床应用受到了限制。我们对BPA的程序进行了完善,以最大程度地发挥其临床疗效。方法和结果:连续对68例无法手术的慢性血栓栓塞性肺动脉高压(CTEPH)患者进行了BPA。我们通过使用血管内超声评估了肺动脉直径并确定了合适的球囊大小。我们以分阶段的方式在多个单独的过程中进行了BPA,以最大程度地提高疗效并降低再灌注肺损伤的风险。每位患者总共进行了4次(2-8)疗程,每次疗程扩张的血管数为3(1-14)。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号